LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA – AbbVie Inc. Transaction History
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA portfolio value:
$8.99M
portfolio value
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA quarter portfolio value change:
-12.37%
quarter
AbbVie Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.45% | -306 shares | -1.31M | $134.21 | 67.02K |
| Q2 2022 | share | Increase | +1.13% | 752 shares | -481K | $153.16 | 67.33K |
| Q1 2022 | share | Decrease | -4.67% | -3.26K shares | 1.33M | $162.11 | 66.57K |
| Q4 2021 | share | Decrease | -8.18% | -6.21K shares | 1.25M | $135.93 | 69.84K |
| Q3 2021 | share | Increase | +0.73% | 550 shares | -301K | $106.6 | 76.06K |
| Q2 2021 | share | Increase | +1.87% | 1.38K shares | 484K | $110.09 | 75.51K |
| Q1 2021 | share | Decrease | -7.54% | -6.04K shares | -569K | $104.49 | 74.12K |
| Q4 2020 | share | Decrease | -0.32% | -260 shares | 1.54M | $102.27 | 80.17K |
| Q3 2020 | share | Decrease | -3.92% | -3.28K shares | -1.17M | $82.47 | 80.43K |
| Q2 2020 | share | Decrease | -1.38% | -1.17K shares | 1.75M | $91.35 | 83.71K |
| Q1 2020 | share | Decrease | -4.17% | -3.69K shares | -1.37M | $69.88 | 84.88K |
| Q4 2019 | share | Decrease | -5.14% | -4.80K shares | 772K | $80.14 | 88.58K |
| Q3 2019 | share | Increase | +1.60% | 1.47K shares | 387K | $67.55 | 93.38K |
| Q2 2019 | share | Decrease | -2.72% | -2.57K shares | -930K | $63.9 | 91.91K |
| Q1 2019 | share | Decrease | -6.39% | -6.45K shares | -1.69M | $69.89 | 94.48K |
| Q4 2018 | share | Increase | +1.31% | 1.30K shares | -118K | $78.96 | 100.93K |
| Q3 2018 | share | Decrease | -5.54% | -5.84K shares | -349K | $80.16 | 99.62K |
| Q2 2018 | share | Decrease | -4.91% | -5.44K shares | -727K | $77.74 | 105.47K |
| Q1 2018 | share | Decrease | -0.28% | -306 shares | -258K | $78.6 | 110.91K |
| Q4 2017 | share | Decrease | -0.29% | -319 shares | 845K | $79.74 | 111.22K |
| Q3 2017 | share | Decrease | -1.53% | -1.73K shares | 1.99M | $72.76 | 111.54K |
| Q2 2017 | share | Increase | +1.32% | 1.47K shares | 635K | $58.85 | 113.28K |
| Q1 2017 | share | Decrease | -2.51% | -2.87K shares | 103K | $52.36 | 111.80K |
| Q4 2016 | share | Increase | +9.01% | 9.47K shares | 546K | $49.8 | 114.68K |
| Q3 2016 | share | Increase | +0.06% | 67 shares | 127K | $49.69 | 105.20K |
| Q2 2016 | share | Increase | +6.95% | 6.83K shares | 894K | $48.35 | 105.14K |
| Q1 2016 | share | Decrease | -5.86% | -6.12K shares | -571K | $44.19 | 98.30K |